Вы находитесь на странице: 1из 8

Fomat

Field
Patient
Patient
Patient
Patient

lD
Last name
First name
Ml

Sample date
Sample time start
Sample time end
Channel number
Sample description
Sample type
Site lD
Operator lD
Ordered By
lnterpretation reported
Temperature
lnterpretation reported by
lnterpretation date
Surgeon

Anesthesiologist
Pathologist
Hemotologist
Perfusionist
Cardiologist
Procedure name

Comment
Flag

Flag2
Flas 3

Angle
MA
PMA
G
PG
EPL

cl
cL30
LY3O

String
String
String
String

(S0char)
(5Ochar)

(S0char)
(5Ochar)

Short date (system)


Short time (system)
Short time (system)
lnteger (2byte)
String (SOchar)
String (5Ochar)
String (5Ochar)
String (S0char)
String (S0char)
String (255char)
Long (4bytes)
$tring (S0char)
Short date (system)
String (S0char)
String (S0char)
String (50char)
String (SOchar)
String (5Ochar)
String (5Ochar)
String (S0char)
String (Appx. 300 char)
String (S0char)
String (S0char)
Strinq (S0char)

Integer (zbyte)
Integer (2byte)
Integer (2byte)
lnteger (2byte)
lnteger (2byte)
Long (4byte)
lnteger (2byte)
Integer (2byte)
Integer (2byte)
Integer (2byte)
Integer (2byte)
Integer (zbyte)
Integer (2byte)
Integer (2byte)
Integer (2byte)
Integer (2byte)
Integer (2byte)
Integer (2byte)
Integer {2byte)

Example
P1A34Z
Anderson
Bob
K
1t11t2001
11:12:O2

11:12:02

baseline
Kaolin

oR-3
ER

Todd
hypercoagulable
37
Bob
1t11t2001

Joe Doe
Rick Smith

MichaelSmith
Tom Doe
Darek Smith
Anna Doe
CABG
patient treated with anticoagulants
Anything 1
Anything 2
Anythins 3

1.0
80.

49.
0.

4800.
1.

15.

47.
0.

49.
100.0
8.

49.0
100.0

0.0
79.5
2.0
1.0

lrun
le

llnteger
ltnteqer

(2byte)
(2bvte)

Test properties

Format

AbnormalFlags
Status
Range

String
String
String
Strino

Value

16.01
96.01

Example

(S0char)
(S0char)

Anything 4
lnterim

(5Ochar)
(5Ochar)

.5 -- 13.7
10.0

LIS Integration Policy


Haemoscope Corporation and its parent company: Haemonetics Corporation, strive to
provide the best in blood managemenf patient care, and customer support. Haemoscope
has developed the TEG@ Analytical Sofrware's (TAS) Lab Information System (LIS)
basic interface and will provide this interface free of charge to Haemoscope customers.
In order to prevent confusion with those sites that do not have LIS capabilities, and to
ensure that it is used properly, the TAS's LIS interface is hidden, and can be unlocked
with a key received from Haemoscope.

Included in the free, basic LIS interface is the following:


LIS interface record specifications and examples as currently available
LIS interface activation code
LIS interface user documentation
Technical support related to the functioning of the TAS's LIS interface
Included fields:'
Patient ID

o
o
o
r
o

o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o
o

PatientName
Sample
Sample
Sample
Sample
Sample
Site ID

Date

Start/End time
channel number
description
type

Operator ID
Ordered By
Inteqpretation reported

Interpretation reported by
Interpretation date
Temperature
Surgeon

Anesthesiologist
Pathologist
Hernatologist
Perfusionist

Cardiologist
Procedure name

Comment

t
This list is for informational purposes only, and is not meant to be used to develop the actual LIS
interface. Field availabilrty may be subject to TAS version and continued development.

LIS Frequently Asked Questions:

Q: What computer requirements are necessary for using the LIS interface?
A: No specific computer specifications are needed to run the LIS interface. If the computer can
run the TAS and connect to the LIS server, then the LIS interface will work.
Q: What versions include the LIS interface?
A: Version 4.2,3 of the TEG@ Analytical Software and above include the LIS interface.
Q: How do I use the LIS interface?
A: The first thing to do is to contact your LIS provider about interfacing with the TAS.2 your
provider can then contact Haemoscope directly to get the LIS interface specificationso and work
through any issues that may arise. Dependrng on your LIS provider, they may already have an
interface developed for the TAS.

Q; My LIS provider has an interface to the TAS, what is the next step?
A: You will need to run the LIS activation utility and get an activation code from Haemoscop,
and then set some LIS specific settings. Detailed instructions are available &om Haemoscope
upon request, as details may change as new versions are developed.

Q: How do I send a sample record to my LIS server?


A: A couple of minutes after sample termination, it is automatically sent to the LIS server. There
is not currently an option to manually initiate a sample transfer.

Q: Is the picture ofthe tracing included in the LIS record?


A: No, only the test results and sample identifying information are included. The tracing itself is
not included in the LIS record.
Q: Is the accession number included in the LIS record?
A: No, the accession number field is not included. Howevero the accession number can be
entered into a sarnple's description field, or a patient's procedure

field.

Both ofthese fields are

transfened as part ofthe LIS record.

Q: Our LIS server was unavailable when the sample terminated, how do we get the sample record
to our seryer once it is available again?
A: If a record was not sent to the LIS server at termination for any reason (e.g. computer crash,
network trouble, the LIS was not yetaclrivate$ etc,) it cannot be sent to the LIS interface. There
is not currently an option to manually initiate a sample transfer.
Q: A sample had the wrong patient name when sent to the LIS server. We fixed the problem in
the TAS, how can we change the record on our LIS server?

A: Once the TAS sends a record, you cannot modiff that record on the server by going through
the TAS. You will have to go through your LIS interface, and change the record manually, if
your LIS server supports modifications.
Q: Is the LIS interface two way? Can the TAS retrieve orders or patient names from the LIS
server?

A: No, the TAS can only send data. Except for the acknowledgement that
the LIS server, the TAS cannot receive any data from the LIS server.
2

a record has reached

Please be aware thd your LIS provider may charge a fee for creating an interface to the
not be covered by Haemoscope, and is the customer's responsibility.

will

TAS. This fee

Instructions for the Laboratory Information System (LlS)


Note:You willneed an activation code from Haemoscope.

Activation
To activate the Laboratory Information System (LtS):

1.

Open the LIS activation. lf the file has not been moved, the default location is
C :\Program Files\TEGV4.

Enter activalim code


I

LlS

irdivemtl:

Ente{ cu$tom eflpirdim

wani}o rersqe;

Cwent apilalim rrrsnirE me$agc:

LIS adivation utility window with the Activate button ac:tive.

2.

Enter your activation code in the 'Enter activation code:" field. The Activate
button will be active. Once the LIS feature has been activated, the "LlS is active
until:" field will be populated with the new expiration date. (Note: The Lls
activation code is case sensitive.)

Instructions for the Laboratory Information System

Steps 3 and 4 are optional (Warning message customization).

3.

4.

You may enter a custom waming message in the "Enter custom expiration
warning message:'field. The Save button will become active.
Click the Save button and "Cunent expiration warning message:'field changes to
the text you entered.

5.

Click the Activate button to activate the utilify.

The warning message appears as the expiration date approaches.

JAS File
The socket configuration and the Ll$ format must be set in the TAS file. open the
TAS.lNl. lf the file has not been moved, the default location is C:\Program Files\TEGV4.
To set the socket configuration, enter the specific lP address after
after LfSPort=.

LIsIp= ohd the port

lf the Lls is being set up with a version 4.2.3 database, set HLTversion equalto 1
(HLTversion=l). lf the LIS was set up with a database earlier than version 4.2.3, set
HlTVersion equal to 0 (HL7Ve rsi on=0).

After making changes to the file, exit the sofrrrare, and restart the softrvare for the
changes to take effect.

Current Amplitude

mm

A30

Amplitude at 30 min after MA

mm

460

Amplitude at 60 min after MA

mm

Angle

Angle; Kinetics of Clot Development

deg

BIV

Bivalirudin

pg/ml

ccs

Cunent Clot Strength

mm/min

CCSG

Current Clot Strength using G

dcs

cl

Coagulation lndex

cL30

Fibrinolytic Status 30 min after MA

o/o

cL60

Fibrinolytic Status 60 min after MA

Yo

CLT

Clot Lysis Time

min

Elasticity Constant

d/sc

EPL

Estimated Percent Lysis

Clot Firmness as Shear Elastic Modulus

disc

Time from R to 20 mm

mtn

Area of Clot Lysis

mm/min

LG

Area of Clot Lysis Using G

dcs

LY3O

Percent Lysis 30 min after MA

o/o

LY6O

Percent Lysis 60 min after MA

o/o

MA

Maximum Amplitude

mm

MRL

Maximum Rate of Lysis

mm/min

MRLG

Maximum Rate of Lysis Using G

dcs

MRTG

Maximum Rate of Thrombus Generation

mm/min

MRTGG

Maximum Rate of Thrombus Generation Using G

dcs

PMA

Projected MA

Reaction Time; Amplitude = 2 mm

mln

SP

Split Point

min

TEG ACT

TEG Activated Clotting Time

sec

TG

Total Thrombus Generated

mny'min

TGG

TotalThrombus Generated Using G

dcs

TMA

Time to MA

min

TMRL

Time to Maximum Rate of Lysis

mrn

TMRLG

Time to Maximum Rate of Lysis Using G

mtn

TMRTG

Time to Maximum Rate of Thrombus Generation

mtn

TMRTGG

Time to Maximum Rate of Thrombus Generation Using G

mrn

TPI

Thrombodynamic Potential lndex

/sec

66s = (dyn/cm2lsec)t2

d/sc = dynlcm2

TEG--SdmFl e-Data
Hemostasi s Anal yzer | | I | 2003081-41-30826 | | oRU^R011 1000011 P | 2 . 1 I
lrEG
PrDl ^-\&
555-xl Iooen:ohnnl
| |1555-xl
oBR i 1 i | | | | | 2O02922217s4A9120020222183s19 |
OBX ri srichannel numberl 1l 1l
sri sample description I 1l (abrogated platelets) I
oBXl 2z |i srl
le type I| r1l Kl
srl samp
sample
oexl J3 I| STI
oBXl
oBXl 4 | srl ordered byl 1l
neported I
reporteol| 1-rl| Report
on reported
Interpretatlon
sr i rnterpretiti
oBXl 5 i| STI
oexi ei srirempei'ature | 1l 37 | degrees celsius I
oBxl 7 I srl rnterpretation date | 1l
oBXl 8 | srl surqeon I 1-l Dr. smith I
oBX i 9 i sr ianesthesi ol osi st | 1- I or . rrank
oex i rO I sr I pathol ogi stl I I Bi cF smi th I
oex i rr i sr i uemotol5si st | 1 | Bob smi th I
oBXi 12 i srl perfusioni st I 1l loe smith
osx i tl i sr lcardi ol ogi st | L l pti ke smi th I
oBXi 14i sri procedure namel l-l some procedurel
MSH

oBX | 15

oexl25 srlPGlLl
oBX | 26
oBX I 27

oex I 28
oBX | 29
OBX 30

OBX 31
OBX 3Z
OBX 33
4l
OBX 34

OBX
OBX
OBX
OBX
OBX

35sl

-- 15lrnteriml
srlcrl1l3.2l l-3 -- 3l
sr lA30 | | 64.4
I rnteri
sricL30l 1l 100 .ol%193 -- 1001 rnteriml
srl lv30l 1l0l%10 -- 8 rnteriml

srlEPLlll0l%10
srlAl1l64.6lmml

I mm

1-

srl460l1l lmml
srlcL60lll l%l
srlLY60lll l%l

srlclrl

1l 19.

5 | mi n

mI

rnteriml

srlsplll2.0lminl
377l srlrPr | 1l 33.61/secl3z
388l srlrurlll20.6lminl

36
6l

-- 527
39
sl srl E I LlL79.Old/cm?lL?0 *- 2641
|

eage 1